Study to Assess the Effect of Renal Impairment on the Pharmacokinetics of CTP-543
Clinical trial NCT05468749 · COMPLETED
Trial details
- NCT number
- NCT05468749
- Sponsor
- Concert Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-06
- Primary completion
- 2022-10-20
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.